01 1Curia
01 1OLOPATADINE HYDROCHLORIDE (PROCESS I)
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-03-02
Pay. Date : 2016-02-12
DMF Number : 19526
Submission : 2006-06-14
Status : Active
Type : II
20
Curia Spain Sau, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is OLOPATADINE HYDROCHLORIDE (PROCESS I), with a corresponding US DMF Number 19526.
Remarkably, this DMF maintains an Active status since its submission on June 14, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 02, 2016, and payment made on February 12, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
